Intrahepatic cholangiocarcinoma: interpretation of expert consensus and guideline from domestic and abroad

doi:10.16139/j.1007-9610.2021.02.008

Abstract

CLC Number:

R735.8

WANG Chong, CHENG Shi. Intrahepatic cholangiocarcinoma: interpretation of expert consensus and guideline from domestic and abroad[J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 124-129.

References 33

[1]	Aloia T, Pawlik TM, Taouli B, et al. Cancer Staging Ma-nual[M]. 8th edition. New York: Springer, 2017:295-302.
[2]	Florio AA, Ferlay J, Znaor A, et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012[J]. Cancer, 2020, 126(11):2666-2678.
[3]	Chun YS, Javle M. Systemic and adjuvant therapies for intrahepatic cholangiocarcinoma[J]. Cancer Control, 2017, 24(3):1073274817729241.
[4]	Weber SM, Ribero D, O′Reilly EM, et al. Intrahepatic cholangiocarcinoma: expert consensus statement[J]. HPB (Oxford), 2015, 17(8):669-680.
[5]	国际肝胆胰学会中国分会, 中华医学会外科学分会肝脏外科学组. 胆管癌诊断与治疗—外科专家共识[J]. 临床肝胆病杂志, 2015(1):12-16.
[6]	胆道肿瘤专家委员会. CSCO胆道系统肿瘤诊断治疗专家共识(2019年版)[J]. 临床肿瘤学杂志, 2019, 24(9):828-838.
[7]	National Comprehensive Cancer Network. Hepatobiliary Cancers, Version 5[J/OL]. 2020-08-04. https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf.
[8]	科技部传染病防治重大专项课题“病毒性肝炎相关肝癌外科综合治疗的个体化和新策略”专家组. 肝内胆管癌外科治疗中国专家共识(2020版)[J]. 中华消化外科杂志, 2021, 20(1):1-15.
[9]	Goere D, Wagholikar GD, Pessaux P, et al. Utility of staging laparoscopy in subsets of biliary cancers: laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma[J]. Surg Endosc, 2006, 20(5):721-725. pmid: 16508808
[10]	Nakanuma Y, Curado MP, Franceschi S, et al. Intrahe-patic cholangiocarcinoma[M]. 4th edition.Lyon: IARC Press, 2010:217-222.
[11]	Liau JY, Tsai JH, Yuan RH, et al. Morphological subclassification of intrahepatic cholangiocarcinoma: etiolo-gical, clinicopathological, and molecular features[J]. Mod Pathol, 2014, 27(8):1163-1173.
[12]	Krasinskas AM. Cholangiocarcinoma[J]. Surg Pathol Clin, 2018, 11(2):403-429. doi: S1875-9181(18)30005-9 pmid: 29751883
[13]	Spolverato G, Bagante F, Weiss M, et al. Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma[J]. J Surg Oncol, 2017, 115(6):696-703. doi: 10.1002/jso.24569 pmid: 28194791
[14]	Kang SH, Hwang S, Lee YJ, et al. Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer staging system for intrahepatic cholangiocarcinoma[J]. J Hepatobiliary Pancreat Sci, 2018, 25(4):240-248.
[15]	Yamamoto Y, Sugiura T, Okamura Y, et al. The evaluation of the eighth edition of the AJCC/UICC staging system for intrahepatic cholangiocarcinoma: a proposal of a modified new staging system[J]. J Gastrointest Surg, 2020, 24(4):786-795. doi: 10.1007/s11605-019-04185-1 pmid: 31012045
[16]	Wang Y, Li J, Xia Y, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy[J]. J Clin Oncol, 2013, 31(9):1188-1195.
[17]	董家鸿, 郑树森, 陈孝平, 等. 肝切除术前肝脏储备功能评估的专家共识(2011版)[J]. 中华消化外科杂志, 2011, 10(1):20-25.
[18]	中华医学会数字医学分会, 中国医师协会肝癌专业委员会, 中国医师协会精准医学专业委员会, 等. 原发性肝癌三维可视化技术操作及诊疗规范(2020版)[J]. 中国实用外科杂志, 2020, 40(9):991-1011.
[19]	Spolverato G, Yakoob MY, Kim Y, et al. The impact of surgical margin status on long-term outcome after resection for intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2015, 22(12):4020-4028. doi: 10.1245/s10434-015-4472-9 pmid: 25762481
[20]	Yoh T, Cauchy F, Le Roy B, et al. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: a multicenter study[J]. Surgery, 2019, 166(6):975-982.
[21]	程石, 王冲. 肝内胆管细胞癌的外科治疗策略[J]. 国际外科学杂志, 2020, 47(6):365-368.
[22]	Sapisochin G, Facciuto M, Rubbia-Brandt L, et al. Liver transplantation for "very early" intrahepatic cholangiocarcinoma: international retrospective study supporting a prospective assessment[J]. Hepatology, 2016, 64(4):1178-1188. doi: 10.1002/hep.28744 pmid: 27481548
[23]	Rana A, Hong JC. Orthotopic liver transplantation in combination with neoadjuvant therapy: a new paradigm in the treatment of unresectable intrahepatic cholangiocarcinoma[J]. Curr Opin Gastroenterol, 2012, 28(3):258-265.
[24]	Sahai P, Kumar S. External radiotherapy and brachythe-rapy in the management of extrahepatic and intrahepatic cholangiocarcinoma: available evidence[J]. Br J Radiol, 2017, 90(1076):20170061.
[25]	Ebata T, Hirano S, Konishi M, et al. Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer[J]. Br J Surg, 2018, 105(3):192-202. doi: 10.1002/bjs.10776 pmid: 29405274
[26]	Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer(BILCAP): a randomised, controlled, multicentre, phase 3 study[J]. Lancet Oncol, 2019, 20(5):663-673. doi: S1470-2045(18)30915-X pmid: 30922733
[27]	Mizusawa J, Morizane C, Okusaka T, et al. Randomized Phase Ⅲ study of gemcitabine plus S-1 versus gem-citabine plus cisplatin in advanced biliary tract cancer: Japan Clinical Oncology Group Study(JCOG1113, FUGA-BT)[J]. Jpn J Clin Oncol, 2016, 46(4):385-388. doi: 10.1093/jjco/hyv213 pmid: 27025903
[28]	Phelip JM, Vendrely V, Rostain F, et al. Gemcitabine plus cisplatin versus chemoradiotherapy in locally advanced biliary tract cancer: Fédération Francophone de Cancérologie Digestive 9902 phaseⅡ randomised study[J]. Eur J Cancer, 2014, 50(17):2975-2982.
[29]	Jackson MW, Amini A, Jones BL, et al. Treatment selection and survival outcomes with and without radiation for unresectable, localized intrahepatic cholangiocarcinoma[J]. Cancer J, 2016, 22(4):237-242.
[30]	Le DT, Uram JN, Wang H, et al. PD-1 blockade in tumors with mismatch-repair deficiency[J]. N Engl J Med, 2015, 372(26):2509-2520.
[31]	Abou-Alfa GK, Sahai V, Hollebecque A, et al. Pemigatinib for previously treated, locally advanced or metasta-tic cholangiocarcinoma: a multicentre, open-label, phase 2 study[J]. Lancet Oncol, 2020, 21(5):671-684. doi: S1470-2045(20)30109-1 pmid: 32203698
[32]	Boehm LM, Jayakrishnan TT, Miura JT, et al. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma[J]. J Surg Oncol, 2015, 111(2):213-220.
[33]	Spolverato G, Kim Y, Alexandrescu S, et al. Management and outcomes of patients with recurrent intrahepatic cholangiocarcinoma following previous curative-intent surgical resection[J]. Ann Surg Oncol, 2016, 23(1):235-243. doi: 10.1245/s10434-015-4642-9 pmid: 26059651

Intrahepatic cholangiocarcinoma: interpretation of expert consensus and guideline from domestic and abroad

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 33

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	ZHANG Hongzhan, ZHANG Kai. Current status and prospect of endoscopic photodynamic therapy for unresectable extrahepatic cholangiocarcinoma and ampullary carcinoma [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 316-320.
[2]	ZHU Siwei, YIN Xinmin. Laparoscopic radical resection of hilar cholangiocarcinoma: current status and considerations [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 100-103.
[3]	LI Xiangcheng, CHEN Yananlan, LI Changxian. Vascular reconstruction in radical resection for hilar cholangiocarcinoma [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 104-109.
[4]	XING Ying, CHENG Shi. Neoadjuvant therapy for gallbladder cancer: current status and challenge [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 110-114.
[5]	LUO Fangxiu, MA Qianchen, YUAN Fei. The fifth edition of WHO classification of digestive system tumors: update and progress on biliary system tumors [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 124-131.
[6]	WANG Yuanjiang, ZOU Hao. Clinical study on comprehensive treatment of gallbladder cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 171-176.
[7]	CHEN Xuanwu, YANG Chuanyu, JIANG Minjie, DU Weidong. Progress of study on gallbladder adenomyomatosis: pathogenesis, diagnosis and treatment [J]. Journal of Surgery Concepts & Practice, 2022, 27(01): 87-90.
[8]	WANG Kaiyu, WANG Liang, SHU Bin, ZHANG Yuewei, HUANG Xin, GE Xiaqing, XIAO Ming, ZHANG Qijia, YAN Zhe, SONG Yan, XIANG Canhong. Radical resection of hilar cholangiocarcinoma combined with left hepatectomy and resection of ventral segment of right anterior sector: one case report [J]. Journal of Surgery Concepts & Practice, 2021, 26(05): 441-444.
[9]	WU Wenta, LI Wei, CAO Yijun. Diagnosis and treatment of xanthogranulomatous cholecystitis [J]. Journal of Surgery Concepts & Practice, 2021, 26(03): 271-274.
[10]	WU Gang, CAI Duan. Surgical treatment of gallbladder polyp: controversy and strategy [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 107-110.
[11]	LI Jingdong, ZHU Jianjiao, ZHANG Lixin, XIONG yongfu. Laparoscopic radical resection of hilar cholangiocarcinoma: controversy and consensus* [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 115-119.
[12]	CHEN Danlei, SHAO Chenghao. Controversy in minimally invasive treatment of distal cholangiocarcinoma and key technical points [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 120-123.
[13]	LIU Hongzhi, LIN Ziguo, HUANG Jianlong, ZHOU Weiping, CHENG Zhangjun, LOU Jianying, ZHENG Shuguo, BI Xinyu, WANG Jianming, GUO Wei, LI Fuyu, WANG Jian, ZHENG Yamin, LI Jingdong, CHENG Shi, LIU Jingfeng, ZENG Yongyi. Effect of surgical margin width on prognosis in patients with single intrahepatic cholangiocarcinoma from a multicenter study [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 130-137.
[14]	SI Anfeng, LEI Zhengqing, YANG Pinghua, JIANG Tao, WANG Xuan, CHENG Zhangjun. Effectiveness of postoperative transarterial chemoembolization for huge intrahepatic cholangiocarcinoma [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 138-143.
[15]	WANG Jiaqi, MA Youwei, XIAO Shuangtao, HUANG Yuda, YU Zhihao, LI Zheng, ZHENG Yamin. Analysis of predictive factors for gallbladder cholesterol polyp and gallbladder adenoma before surgery [J]. Journal of Surgery Concepts & Practice, 2021, 26(02): 144-148.